(S1 (S (NP (JJ High) (NN LMP1) (NN Expression)) (VP (VBZ Correlates) (PP (IN with) (NP (NP (DT the) (NN Development)) (PP (IN of) (NP (NN Lymphoma))))))))
(S1 (S (NP (NN LMP1) (NN expression)) (VP (VBZ is) (VP (VBN shown) (PP (IN by) (NP (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (NN immunoblotting)) (PP (IN of) (NP (NP (VBN purified) (NN B) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN CD19+)) (-RRB- -RRB-))))) (CC and) (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (NN immunohistochemistry) (NN staining)) (PP (IN of) (NP (NP (NN spleen) (NN tissue)) (PP (IN from) (NP (NP (NP (JJ wild-type)) (PRN (-LRB- -LRB-) (NP (NN WT)) (-RRB- -RRB-))) (CC and) (NP (NN LMP1)) (NP (JJ transgenic) (NNS mice))))))))))) (. .)))
(S1 (S (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (NNS Lymphomas)) (VP (VBP are) (VP (VBN identified) (PP (IN with) (NP (NP (DT a) (NN number)) (PRN (-LRB- -LRB-) (NP (NN 1-7)) (-RRB- -RRB-))))))) (. .)))
(S1 (S (S (NP (NNS Arrows)) (VP (VBP indicate) (NP (NP (DT the) (JJ LMP1-specific) (NN band)) (CC and) (NP (PRP$ its) (NN degradation) (NNS products)) (CONJP (RB as) (RB well) (IN as)) (NP (DT a) (JJ non-specific) (NN band))))) (. .)))
(S1 (S (S (NP (NN Actin)) (VP (VBD was) (VP (VBN used) (PP (IN as) (NP (DT a) (NN loading) (NN control)))))) (. .)))
(S1 (S (S (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (S (NP (ADJP (ADJP (JJ White)) (CC and) (ADJP (JJ red))) (NNS pulps)) (VP (VBP are) (VP (VBN shown)))) (, ,) (CC but) (S (NP (DT this) (NN architecture)) (VP (VBZ is) (VP (VBN lost) (PP (IN upon) (NP (NP (NN development)) (PP (IN of) (NP (NN lymphoma))))))))) (. .)))
(S1 (S (S (VP (VBP Scale) (NP (NP (NN bar)) (, ,) (NP (CD 20) (NN mum))))) (. .)))
